药剂师对爱尔兰社区药房环境中社会隔离和孤独 (SIL) 的表现的看法 - 一项混合方法研究
Jung-Ah Hong1, Hebah Al-Rashed1, Laura Rice1
1School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, St Stephens Green, Dublin, Ireland.
Exploratory research in clinical and social pharmacy
|December 16, 2025
概括
社区药房可以帮助打击社会隔离和孤独 (SIL). 药剂师经常遇到SIL,但需要更好的培训,资源和与其他服务的整合,以有效地支持患者.
科学领域:
- 公共卫生 公共卫生
- 社会科学 社会科学 社会科学
- 药房实践 在药房实践.
背景情况:
- 社会孤立和孤独 (SIL) 是与健康状况不佳相关的重大公共卫生问题.
- 社区药房是潜在干预措施的可访问点.
- 关于SIL在社区药房中的表现存在知识差距.
研究的目的:
- 从执业药剂师的角度探索SIL在社区药房中的表现.
- 确定药剂师为患有SIL的患者提供支持的促进者和障碍.
主要方法:
- 使用混合方法的方法,将社区药剂师的半结构面试 (n=9) 和全国调查 (n=95) 结合起来.
- 定性采访数据以主题分析.
- 调查数据证实了采访结果.
主要成果:
- 药剂师经常遇到SIL,特别是在老年人中,经常通过药品护理问题间接地识别它.
- 确定的主要主题是SIL的认可,风险因素,促进因素和支持障碍.
- 障碍包括缺乏培训,标志知识和资源限制.
- 药剂师报告说,他们非常想帮助,但需要加强指导和资源.
结论:
- 社区药房有潜力成为促进社会连接的干预措施的场所.
- 有效实施需要将药房服务与更广泛的支持系统相结合,提供足够的资源,并纳入药房教育.
- 基于患者的共同设计对于在药店开发成功的SIL支持服务至关重要.
更多相关视频
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Social Relationships and Well-Being
227
The significance of social relationships in psychological well-being is a well-established area of inquiry within social psychology. Research consistently demonstrates that the presence of meaningful, supportive relationships enhances emotional health, while the absence or deterioration of such connections can contribute to psychological distress. Relationships serve as a foundation for emotional support, identity, and social belonging, all of which are critical to an individual’s overall...
227
Analysis of Population Pharmacokinetic Data
653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
215
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208


